Market Challenges And Opportunities

Restraints & Challenges:

Global Organ Transplant Immunosuppressant Drugs Market - Drivers

Increasing incidences of chronic diseases: Increasing incidences of chronic diseases is expected to propel the growth of the global organ transplant immunosuppressant drugs market over the forecast period. For instance, according to World Health Organization (WHO) report published in September 2022, chronic diseases account for 41 million annual fatalities, or 74% of all fatalities worldwide. The majority of chronic diseases or non- communicable diseases (NCDs), with 17.9 million fatalities each year, which are caused by cardiovascular illnesses, followed by malignancies like cancer and tumor (9.3 million), chronic respiratory conditions (4.1 million), and diabetes (2.0 million, including deaths from renal disease brought on by diabetes).
Increasing geriatric population: Ageing is associated with a higher risk of organ failure, as many organs naturally decline in function with age. Common age-related organ failures include kidney, heart, liver, and lung diseases. As people age, they are more likely to require organ transplants to extend their lives, thus increasing the demand for immunosuppressant drugs. For instance, according to World Health Organization report published in October 2022, in 2020, there will be more persons over 60 than under five-year-olds. The percentage of people over 60 in the world will nearly treble from 12% to 22% between 2015 and 2050.

Organ Transplant Immunosuppressant Drugs Market Report Snapshots